BR112012004169A2 - intervenções de emergência com carvão vegetal ativado em superdosagem de etexilato de dabigatran - Google Patents

intervenções de emergência com carvão vegetal ativado em superdosagem de etexilato de dabigatran

Info

Publication number
BR112012004169A2
BR112012004169A2 BR112012004169A BR112012004169A BR112012004169A2 BR 112012004169 A2 BR112012004169 A2 BR 112012004169A2 BR 112012004169 A BR112012004169 A BR 112012004169A BR 112012004169 A BR112012004169 A BR 112012004169A BR 112012004169 A2 BR112012004169 A2 BR 112012004169A2
Authority
BR
Brazil
Prior art keywords
overdose
activated charcoal
dabigatran etexilate
emergency interventions
interventions
Prior art date
Application number
BR112012004169A
Other languages
English (en)
Portuguese (pt)
Inventor
Andreas Clemens
Joanne Van Ryn
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BR112012004169A2 publication Critical patent/BR112012004169A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112012004169A 2009-08-24 2010-08-23 intervenções de emergência com carvão vegetal ativado em superdosagem de etexilato de dabigatran BR112012004169A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23632109P 2009-08-24 2009-08-24
PCT/EP2010/062229 WO2011023653A1 (en) 2009-08-24 2010-08-23 Emergency interventions of active charcoal with dabigatran etexilate overdosing

Publications (1)

Publication Number Publication Date
BR112012004169A2 true BR112012004169A2 (pt) 2016-03-29

Family

ID=42740360

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012004169A BR112012004169A2 (pt) 2009-08-24 2010-08-23 intervenções de emergência com carvão vegetal ativado em superdosagem de etexilato de dabigatran

Country Status (20)

Country Link
US (2) US20110206656A1 (enExample)
EP (1) EP2470187B1 (enExample)
JP (1) JP2013502449A (enExample)
KR (1) KR20120050457A (enExample)
CN (1) CN102481317B (enExample)
AR (1) AR077909A1 (enExample)
AU (1) AU2010288601A1 (enExample)
BR (1) BR112012004169A2 (enExample)
CA (1) CA2767966A1 (enExample)
CL (1) CL2012000488A1 (enExample)
DK (1) DK2470187T3 (enExample)
EA (1) EA201200319A1 (enExample)
ES (1) ES2436076T3 (enExample)
IL (1) IL216968A0 (enExample)
MX (1) MX2012001767A (enExample)
NZ (1) NZ597359A (enExample)
PH (1) PH12012500388A1 (enExample)
PL (1) PL2470187T3 (enExample)
TW (1) TW201124143A (enExample)
WO (1) WO2011023653A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079944A1 (es) 2010-01-20 2012-02-29 Boehringer Ingelheim Int Anticuerpo neutralizante de la actividad de un anticoagulante
AP2013007046A0 (en) * 2011-03-30 2013-08-31 Boehringer Ingelheim Int Anticoagulant antidotes
GB201120693D0 (en) * 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
CN114452839B (zh) * 2022-02-10 2023-04-21 中南大学湘雅医院 一种抗凝抗栓血液净化膜及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5277820A (en) * 1992-02-06 1994-01-11 Hemocleanse, Inc. Device and method for extracorporeal blood treatment
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
DK1485094T4 (da) 2002-03-07 2020-06-22 Boehringer Ingelheim Int Doseringsform til oral indgivelse af 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester eller dets salte

Also Published As

Publication number Publication date
IL216968A0 (en) 2012-02-29
EP2470187A1 (en) 2012-07-04
CN102481317B (zh) 2014-09-03
CL2012000488A1 (es) 2012-08-31
AR077909A1 (es) 2011-09-28
CN102481317A (zh) 2012-05-30
PH12012500388A1 (en) 2012-10-22
CA2767966A1 (en) 2011-03-03
KR20120050457A (ko) 2012-05-18
ES2436076T3 (es) 2013-12-26
EA201200319A1 (ru) 2012-09-28
DK2470187T3 (da) 2013-10-28
TW201124143A (en) 2011-07-16
PL2470187T3 (pl) 2014-01-31
AU2010288601A1 (en) 2012-02-02
US20110206656A1 (en) 2011-08-25
JP2013502449A (ja) 2013-01-24
EP2470187B1 (en) 2013-08-21
US20130302311A1 (en) 2013-11-14
MX2012001767A (es) 2012-02-29
WO2011023653A1 (en) 2011-03-03
NZ597359A (en) 2014-01-31

Similar Documents

Publication Publication Date Title
EP2303394A4 (en) DEVICE FOR TRANSDERMAL ADMINISTRATIONS
PL3593762T3 (pl) Zastawka protetyczna serca i urządzenie do wprowadzania
DK2313395T3 (da) Pyridon- og pyridazonanaloger som GPR119-modulatorer
DK2274032T3 (da) Anordning til medicinindgivelse
BRPI0914789A2 (pt) efeitos sinérgicos
IL209419A0 (en) Modified drugs for use in liposomal nanoparticles
ATE526024T1 (de) Fluvoxamin vermeidende pirfenidontheraphy
BRPI1012295A2 (pt) aperfeiçoamento em substratos de segurança
GB201321470D0 (en) Capturing and manipulating content using biometric data
GB2461610B (en) Methods and systems to facilitate over-speed protection
ZA200905792B (en) Banana treatments
DK2133113T3 (da) Oxygen administreringsapparat
DK3150178T3 (da) Stimuleringsapparat
DK2793866T4 (da) Tolagstablet omfattende benazeprilhydrochlorid og pimobendan
GB201105097D0 (en) Detecting modified behaviour in bees
GB2461608B (en) Methods and systems to facilitate over-speed protection
EP2714394A4 (en) BARRIER STRUCTURE AND LAMINATE THEREFOR
BR112012004169A2 (pt) intervenções de emergência com carvão vegetal ativado em superdosagem de etexilato de dabigatran
EP2413919A4 (en) NICOTINE DISSOLUTION FILM WITH OR WITHOUT MENTHOL
PT3133396T (pt) Métodos de tratamento utilizando fármacos eliminadores de amoníaco
EP2247183A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING PROGRESS FOR CHRONIC HEART FAILURE
EP2515890A4 (en) NEURAL STIMULATION
EP2343963A4 (en) TRANSDERMALE RELEASE
IT1391542B1 (it) Cassaforte
GB2470366B (en) Improvements in or relating to devices for assistance in stopping smoking

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]